Academic detailing

Last updated

Academic detailing is "university or non-commercial-based educational outreach." [1] The process involves face-to-face education of prescribers by trained health care professionals, typically pharmacists, physicians, or nurses. The goal of academic detailing is to improve prescribing of targeted drugs to be consistent with medical evidence from randomized controlled trials, which ultimately improves patient care and can reduce health care costs. A key component of non-commercial or university-based academic detailing programs is that they (academic detailers/clinical educators, management, staff, program developers, etc.) do not have any financial links to the pharmaceutical industry.

Contents

Academic detailing has been studied for over 25 years [2] and has been shown to be effective at improving prescribing of targeted medications about 5% from baseline. [3] Though it is primarily used to affect prescribing, it is also used to educate providers regarding other non-drug interventions, such as screening guidelines.

Organizations

Many academic detailing programs exist around the world. In the United States, university-based state programs exist in Illinois [4] , Vermont, [5] Oregon [6] and South Carolina. [7] The nonprofit organization Alosa Health [8] runs an academic detailing program in Pennsylvania, Massachusetts and Washington, DC called the Independent Drug Information Service (IDIS). The National Resource Center for Academic Detailing (NaRCAD), funded by the Agency for Healthcare Research and Quality (AHRQ) in 2010, was created to help organizations with limited resources to establish and improve their own programs and to create a network of academic detailing programs. The U.S. Department of Veterans Affairs Pharmacy Benefits Management pilot tested the National Academic Detailing Service in 2010 to enhance veterans' outcomes by empowering clinicians and promoting the use of evidence-based treatments using delivered by clinical pharmacy specialists. [9] After the pilot, in March 2015, the Interim Under Secretary for Health issued a memorandum requiring implementation of AD programs throughout the Veterans Health Administration. [10]

Programs also exist in Canada through the Canadian Academic Detailing Collaboration (CADC), [11] including the Centre for Effective Practice's (CEP) academic detailing service [12] in Ontario, [13] and Australia through the Drug and Therapeutics Information Service (DATIS) and the National Prescribing Service (NPS). In Belgium academic detailing is provided by Project Farmaka.

See also

Related Research Articles

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist in Commonwealth English, is a healthcare professional who specializes in the preparation, dispensing, and management of medications. A pharmacist provides pharmaceutical advice and guidance, often serving as a primary care provider in the community, and offering other services, such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

A Doctor of Pharmacy is a professional doctorate in pharmacy. In some countries, it is a proficient graduate degree to practice the profession of pharmacy or to become a clinical pharmacist. In many countries, people with their Doctor of Pharmacy are allowed to practice independently and can prescribe drugs directly to patients. A PharmD program has significant experiential and/or clinical education components in introductory and advanced levels for the safe and effective use of drugs. Experiential education prepares graduates to be practice-ready, as they already have spent a significant amount of time training in areas of direct patient care and research.

Pharmacotherapy, also known as pharmacological therapy or drug therapy, is defined as medical treatment that utilizes one or more pharmaceutical drugs to improve ongoing symptoms, treat the underlying condition, or act as a prevention for other diseases (prophylaxis).

Jerry Avorn' is a professor of medicine at Harvard Medical School and Chief Emeritus of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. He founded one of the largest programs using health care utilization data to track medication use and outcomes, and invented the practice of "academic detailing" in which pharmacists, nurses, and physicians educate doctors about cost-effective prescribing practices using the same tactics that drug companies employ to market their products. He received a B.A. from Columbia University in 1969 and M.D. from Harvard Medical School in 1974.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs, biologics, vaccines and natural health products.

A veterinary pharmacist is a specially trained pharmacist who dispenses veterinary drugs and supplies or products and advice to owners of companion animals and livestock. In addition, they advise the regulatory bodies and are involved in the formulation of veterinary drugs. Veterinary pharmacy is a field of pharmacy practice, in which veterinary pharmacists may compound medications, fill prescriptions, and manage drug therapies for animals. Veterinary pharmacists are licensed pharmacists who specialize in the distribution of medications for animals.

<span class="mw-page-title-main">Clinical pharmacy</span> Branch of pharmacy for direct provision

Clinical pharmacy is the branch of pharmacy in which clinical pharmacists provide direct patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, physician assistants, nurse practitioners, and other healthcare professionals. Clinical pharmacists can enter into a formal collaborative practice agreement with another healthcare provider, generally one or more physicians, that allows pharmacists to prescribe medications and order laboratory tests.

Pharmacy residency is education a pharmacist can pursue beyond the degree required for licensing as a pharmacist. A pharmacy residency program allows for the implementation of skill set and knowledge acquired in pharmacy school through interaction with the public either in a hospital setting or community practice. The program is done over a span of about 2yrs after graduation from pharmacy school and licensure as a pharmacist. Pharmacy residency helps improve the resume of a pharmacist so as to increase chances of obtaining employment outside community practice. A 2022 review suggested that there is sufficient evidence that residency develops key competencies for junior pharmacists.

Electronic prescription is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy. It outlines the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of the major reasons for the push for electronic medical records. By sharing medical prescription information, e-prescribing seeks to connect the patient's team of healthcare providers to facilitate knowledgeable decision making.

Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing education on the disease state and medications used to treat the disease state, ensuring that medicines are taken correctly, reducing waste due to unused medicines, looking for any side effects, and providing education on how to manage any side effects. The process that can be broken down into five steps: medication therapy review, personal medication record, medication-related action plan, intervention and or referral, and documentation and follow-up.

<span class="mw-page-title-main">Leslie Dan Faculty of Pharmacy</span>

The Leslie Dan Faculty of Pharmacy is a pharmacy school and an academic division of the University of Toronto. The school is located on the northwestern corner of College Street and University Avenue, placing it across from the Ontario Legislative Building and at the entrance to Queen's Park station. It is also situated near four internationally renowned hospitals—The Hospital for Sick Children, Princess Margaret Cancer Centre, Toronto General Hospital and Mount Sinai Hospital. It is part of Toronto's Discovery District.

Psychiatric pharmacy, also known as mental health pharmacy, is the area of clinical pharmacy specializing in the treatment of people with psychiatric illnesses through the use of psychotropic medications. It is a branch of neuropsychiatric pharmacy, which includes neurologic pharmacy. Areas where psychiatric pharmacists are found most abundantly are in chemical dependency, developmental disabilities, long-term care facilities, adherence clinics, mental health clinics, and within the prison system. However, psychiatry and neurology are not the only areas where psychiatric pharmacists require comprehensive knowledge. They must also be proficient in clinical problem solving, interprofessionalism, and communication with understanding and empathy for the patient population they serve, as they are a sensitive group.

<span class="mw-page-title-main">Deprescribing</span> Process to taper or stop medications

Deprescribing is a process of tapering or stopping medications to achieve improved health outcomes by reducing exposure to medications that are potentially either harmful or no longer required. Deprescribing is important to consider with changing health and care goals over time, as well as polypharmacy and adverse effects. Deprescribing can improve adherence, cost, and health outcomes but may have adverse drug withdrawal effects. More specifically, deprescribing is the planned and supervised process of intentionally stopping a medication or reducing its dose to improve the person's health or reduce the risk of adverse side effects. Deprescribing is usually done because the drug may be causing harm, may no longer be helping the patient, or may be inappropriate for the individual patient's current situation. Deprescribing can help correct polypharmacy and prescription cascade.

Antimicrobial stewardship (AMS) refers to coordinated efforts to promote the optimal use of antimicrobial agents, including drug choice, dosing, route, and duration of administration.

<span class="mw-page-title-main">Collaborative practice agreement</span> Egal relationship between clinical pharmacists and collaborating physicians

A collaborative practice agreement (CPA) is a legal document in the United States that establishes a legal relationship between clinical pharmacists and collaborating physicians that allows for pharmacists to participate in collaborative drug therapy management (CDTM).

<span class="mw-page-title-main">Drug utilization review</span>

Drug utilization review refers to a review of prescribing, dispensing, administering and ingesting of medication. This authorized, structured and ongoing review is related to pharmacy benefit managers. Drug use/ utilization evaluation and medication utilization evaluations are the same as drug utilization review.

Cara Tannenbaum is a Canadian researcher and practicing physician in the fields of geriatrics, women's health and gender research. Since 2015, Tannenbaum has served as the Scientific Director of Canadian Institutes of Health Research's Institute of Gender and Health. She was appointed as a Member of the Order of Canada on November 17, 2021.

References

  1. ↑ Soumerai SB, Avorn J (1990). "Principles of educational outreach ('academic detailing') to improve clinical decision making". JAMA. 263 (4): 549–56. doi:10.1001/jama.1990.03440040088034. PMID   2104640. S2CID   1981297.
  2. ↑ Avorn J, Soumerai SB (1983). "Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 308 (24): 1457–63. doi:10.1056/nejm198306163082406. PMID   6406886. S2CID   74834805.
  3. ↑ O'Brien MA, Rogers S, Jamtvedt G, et al. (2007). "Educational outreach visits: effects on professional practice and health care outcomes". Cochrane Database Syst Rev. 4 (4): CD000409. doi:10.1002/14651858.cd000409.pub2. PMC   7032679 . PMID   17943742.
  4. ↑ "Illinois ADVANCE | University of Illinois Chicago" . Retrieved 2024-07-01.
  5. ↑ "Vermont Academic Detailing Program". The University of Vermont College of Medicine. Archived from the original on 2011-07-20.
  6. ↑ "Drug Use Research and Management, Oregon State University". July 20, 2011. Archived from the original on 2011-07-20.
  7. ↑ "South Carolina College of Pharmacy - SCORxE". Archived from the original on 2009-01-06. Retrieved 2008-04-17.
  8. ↑ "Alosa Health".
  9. ↑ https://www.pbm.va.gov/PBM/academicdetailingservice/AboutUs.asp (Last accessed: 20 October 2018)
  10. ↑ "STATEMENT OF DR. CAROLYN CLANCY, M.D. INTERIM UNDER SECRETARY FOR HEALTH VETERANS HEALTH ADMINISTRATION (VHA) DEPARTMENT OF VETERANS AFFAIRS (VA) BEFORE THE COMMITTEE ON VETERANS' AFFAIRS UNITED STATES SENATE" (PDF).
  11. ↑ Canadian Academic Detailing Collaboration
  12. ↑ "CEP | Centre for Effective Practice".
  13. ↑ Jin, Margaret; Naumann, Terryn; Regier, Loren; Bugden, Shawn; Allen, Michael; Salach, Lena; Chelak, Kristen; Blythe, Nancy; Gagnon, Antony (May 2012). "A brief overview of academic detailing in Canada: Another role for pharmacists". Canadian Pharmacists Journal. 145 (3): 142–146.e2. doi:10.3821/145.3.cpj142. ISSN   1715-1635. PMC   3567505 . PMID   23509530.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.